Full Course Description

Module 1, Part 1 | Psychopharmacology Conference

Spend three action-packed days learning about the newest advances in psychopharmacology and contemporary trends in medication management. From his unique perspective, Dr. Perry Buffington teaches psychopharmacology thoughtfully, with an emphasis on the experience of the client. Dr. Buffington’s years of experience in mental health and passion for clients, shines through in the detail and thoroughness of his presentation.
Clients often only have a few minutes with their prescriber and require additional support. It’s vital that you are able to answer their questions, help manage side effects and understand reactions. Designed for counselors, nurses, psychotherapists, psychologists, and other mental health professionals, Dr. Buffington provides the information you need in order to best help your clients.
This conference allows time for exploration of underrepresented areas, including AD HD, nutrition, medical drug emergencies, and psychopharmacological ethics. Take home specialized guidelines for geriatrics, pregnant or nursing women, and clients with chronic pain. In addition to a general ‘nuts and bolts’ review of medications, you will examine case examples, discuss medication controversies and how to effectively collaborate with prescribing practitioners. You will find this conference to have the most up- to-date medication information and how to use it most effectively with your client.

Program Information

Target Audience

Counselors, Nurses, Nurse Practitioners, Clinical Nurse Specialists, Psychotherapists, Psychologists, Social Workers, Case Managers, Marriage and Family Therapists, Addiction Counselors, Pharmacists, School Psychologists, Others in caring professions

Objectives

  1. Analyze the historical antecedents of psychopharmacological products and their relation to today’s psychotropic medications.
  2. Identify the mechanism of action of today’s psychotropic medications and how it relates to your clients.
  3. Breakdown the process of medication selection and receptor activation/blocking for specific disorders.
  4. Communicate the side effects including nutritional, cognitive, sexual, and behavioral associated with psychotropic medications.
  5. Communicate options for clients including medications and/or psychotherapy.
  6. Explain how medications are chosen for mood disorders and specific patient characteristics.
  7. Compile medication treatment options for your clients with ADHD.
  8. Determine medication management strategies for clients with sleep disorders.
  9. Identify medications effective for your clients with eating disorders.
  10. Determine how to effectively incorporate medication assisted treatments into an overall care plan for substance use disorders.
  11. Determine the unique medication considerations for geriatric clients.
  12. Discriminate between acute and chronic pain to recommend best methods of treatment.
  13. Analyze future trends, including preventing side effects vs. managing side effects.
  14. Establish ethical issues specifically relating to the child and adolescent population as it relates to clinical psychopharmacology.
  15. Apply traditional standards (autonomy, beneficence, nonmaleficence, confidentiality, veracity) of ethical behavior to issues peculiar to the practice of clinical psychopharmacology.
  16. Explore specific ethical issues and their resolve to the everyday practice of clinical psychopharmacology.
  17. Explain the role of prescriber as both patient advocate and protector.
  18. Evaluate research and its impact on future prescribing and patient care.

Outline

  • Module One
    • Psychopharmacology
      • Historical Antecedents of Modern Psychopharmacology
      • Diagnostic Issues
      • Clarification of Terms
      • Drug Metabolism Concepts: Pharmacokinetics & Pharmacodynamics
      • Drug Mechanism of Action
      • Placebo & Nocebo
      • Pharmacotherapy Vs. Psychotherapy
    • Understanding Receptors
      • Specific Receptors & Their Action
      • Prescribe Based on Receptor Action
    • Masking: Psychological Problems Disguising
    • Medical Disorders
      • Differential Disorders & Diagnostic Workup
      • Top 10 Drug Medical Emergencies
    • Depressive Disorders
      • The Terminal Button & Neuronal Health
      • Biogenic Amine, Cortisol, Down-Regulation, & Neurotropic
      • Hypotheses
      • Neurochemistry of Depression
      • Types of Anti-Depressants
      • Preventing Side Effects
      • Treatment Resistant Depression and Drug Combinations
      • Tardive Dysphoria: Real or Imagined?
    • The Role of Nutrition & Mental Health
      • Monoaminergic Rich Foods
      • Achetylcholinergic Rich Foods
  • Module Two
    • Review of Anti-Depressants
    • Create the Perfect Anti-Depressant
    • Anxiety Disorders & Obsessive Compulsive Disorders & Trauma Related Disorders
      • Gad, Panic Disorders, Phobias
      • OCD
      • PTSD
      • Physiological Interventions
      • Anti-Anxiety Medications
      • Anti-Depressants
      • Non-Pharmacologic Options
      • Benzodiazepines: Risks and Benefits
      • Preventing Side Effects
    • Psychotic Disorders/Schizophrenia
      • Neurochemistry of Psychosis and Schizophrenia
      • Antipsychotic Medications:
      • First Generation (Typical)
      • Second Generation (Atypical)
      • Managing Side Effects
      • Extrapyramidal Symptoms and TD
      • Metabolic Problems
      • Recognizing Hyperprolactinemia - And Why You Need to Know
      • Use of Atypical Antipsychotics for Multiple Disorders
      • Pregnancy and Psychotic Disorders
    • Bipolar Disorders
      • Neurochemistry
      • The Bipolar Spectrum
      • Mood Stabilizers
      • Lithium
      • Anti-Convulsants & Neuromodulators
      • Effective Strategies for Improving Outcomes for Clients

  • Module Three
    • Attentional Disorders
      • Differential Diagnosis
      • Neurochemistry of ADHD
      • Treatment Controversies
      • Substance Abuse and ADHD
      • Stimulant Medications
      • Non-Stimulant Options
      • Preventing Side Effects
    • Substance Abuse Disorders
      • Neurochemistry of Addiction
      • Negative Reinforcement & Creation of Habits
      • Alcohol
      • Caffeine
      • Nicotine
      • Cannabis
      • Opiates
      • PCP & Ketamine
      • MDMA (Ecstasy)
      • Energy Vs. Chill Drinks
      • Over-The-Counter & Herbal
      • Psychopharmacology
      • Addiction Treatments
      • Behavioral Addictions
    • Treating Client Pain
      • Acute Vs. Chronic Pain
      • Advances in Psychopharmacology
      • Alternatives to Psychopharmacology
      • Pain Vs. Depression: Which Comes First?
      • Co-Morbid Pain
      • Alternatives
    • Special Population
      • Specialized Guidelines For Geriatric Patients
      • Dementia Treatment
      • Pregnancy Guidelines
      • Slow Vs. Rapid Metabolizers (Genetic Polymorphisms)
    • Ethics & Psychopharmacology
      • High-Risk Pharmacology & Psychopharmacology
      • Off-Label Use of Medications
      • Prescribing for Children
      • Elective Psychopharmacology
      • Marketing of Mental Illness
      • Polypharmacy
      • Informed Vs. Uninformed Consent
      • Patient & Third Party Pressures
      • Professional Boundaries
      • Ethics Associated with Medical
      • Errors
      • Role of Placebo

Copyright : 07/17/2017

Module 1, Part 2 | Psychopharmacology Conference

Copyright : 07/17/2017

Module 2, Part 1 | Psychopharmacology Conference

Copyright : 07/17/2017

Module 2, Part 2 | Psychopharmacology Conference

Copyright : 07/17/2017

Module 3, Part 1 | Psychopharmacology Conference

Copyright : 07/17/2017

Module 3, Part 2 | Psychopharmacology Conference

Copyright : 07/17/2017

Psychopharmacology

Congratulations to Joe Wegmann, and his book, Psychopharmacology, 3rd Edition, for winning a silver medal at the 2016 IBPA Benjamin Franklin Awards for editorial and design excellence in the Professional & Technical Category.

This is the definitive guide and desk reference for healthcare professionals and patients to expand their knowledge in the pharmacological and behavioral treatment of psychosis, anxiety, depression, bipolar, insomnia and ADHD.

  • New to the third edition:
  • DSM-5® and psychotropic medication prescribing
  • New risk factors with antidepressants
  • Anxiety treatment -- what should not be medicated
  • Herbal and other alternative treatments
  • Latest in geriatric psychopharmacology
  • Psychotropic medication discontinuation-safe strategies that work
  • Additive and combination medication protocols
  • Newly released psychiatric medications
  • Dosage Range Charts

Co-Occurring Disorders

Despite an increased awareness of co-occurring disorders, most current treatment paradigms still focus on one problem or the other, leaving much unassessed, unaddressed, or ignored. Until now - a revolutionary new book from Dr. Charles Atkins that can break the cycles of relapse for those intertwined with substance use and mental illness.

Co-Occurring Disorders is a guide to practical assessment and effective treatment approaches for working with any number of co-occurring disorders. This step-by-step approach, demonstrated through diverse case studies, gives you the tools you need to improve and track your clinical outcomes.

This is a must-have resource for both the rubber-meets-the-road clinician, who wants effective strategies and a clear direction for treatment and recovery, and the administrator who creates interventions at the system level with attention to regulatory and reimbursement demands. Also included is a comprehensive state-by-state Guide to Mental Health and Substance Abuse Agencies and Prescription Monitoring Programs.

Evidence-Based Integrated Treatment, finding the right tool for the job:

  • Motivational Interviewing
  • Cognitive-Behavioral Therapy and Strategies
  • Skills Training
  • Mindfulness Training
  • Mutual Self-Help & Peer-Based interventions
  • Wellness interventions
  • Recovery based
  • Family interventions
  • Assertive Community Treatment and Targeted Case Management
  • Psychopharmacology including opioid and nicotine replacement strategies

 Diagnosis-Specific Issues in Co-Occurring Disorders:

  • ADHD
  • Depression and Bipolar Disorders
  • Anxiety and PTSD
  • Schizophrenia and other Psychotic Disorders
  • Personality Disorders

Substance-Specific Issues in Co-Occurring Disorders:

  • Alcohol
  • Opioids
  • Tobacco
  • Cocaine and other Stimulants, including "Bath Salts"
  • Cannabis & Synthetic Cannabis
  • The Internet and other sources of Drugs